期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Comparative study of microarray and experimental data on Schwann cells in peripheral nerve degeneration and regeneration: big data analysis 被引量:6
1
作者 Ulfuara Shefa Junyang Jung 《Neural Regeneration Research》 SCIE CAS CSCD 2019年第6期1099-1104,共6页
A Schwann cell has regenerative capabilities and is an important cell in the peripheral nervous system.This microarray study is part of a bioinformatics study that focuses mainly on Schwann cells. Microarray data prov... A Schwann cell has regenerative capabilities and is an important cell in the peripheral nervous system.This microarray study is part of a bioinformatics study that focuses mainly on Schwann cells. Microarray data provide information on differences between microarray-based and experiment-based gene expression analyses. According to microarray data, several genes exhibit increased expression(fold change) but they are weakly expressed in experimental studies(based on morphology, protein and mRNA levels). In contrast, some genes are weakly expressed in microarray data and highly expressed in experimental studies;such genes may represent future target genes in Schwann cell studies. These studies allow us to learn about additional genes that could be used to achieve targeted results from experimental studies. In the current big data study by retrieving more than 5000 scientific articles from PubMed or NCBI, Google Scholar, and Google, 1016(up-and downregulated) genes were determined to be related to Schwann cells. However,no experiment was performed in the laboratory; rather, the present study is part of a big data analysis. Our study will contribute to our understanding of Schwann cell biology by aiding in the identification of genes.Based on a comparative analysis of all microarray data, we conclude that the microarray could be a good tool for predicting the expression and intensity of different genes of interest in actual experiments. 展开更多
关键词 Schwann cells big data analysis PERIPHERAL NERVE DEGENERATION PERIPHERAL NERVE REGENERATION MICROARRAY matched genes promising genes gene ranking
下载PDF
子宫内膜癌ProMisE分子分型与淋巴结转移及其他临床特征的关系 被引量:1
2
作者 李园园 李倩 +2 位作者 何莲 朱延美 张新 《国际妇产科学杂志》 CAS 2023年第4期377-381,391,共6页
目的:探讨子宫内膜癌ProMisE分子分型与淋巴结转移及其他临床特征的相关性。方法:选取2014年12月—2018年12月于大连理工大学附属肿瘤医院行手术治疗的子宫内膜癌患者74例,收集患者的临床资料,采用ProMisE方法进行分子分型,比较不同分... 目的:探讨子宫内膜癌ProMisE分子分型与淋巴结转移及其他临床特征的相关性。方法:选取2014年12月—2018年12月于大连理工大学附属肿瘤医院行手术治疗的子宫内膜癌患者74例,收集患者的临床资料,采用ProMisE方法进行分子分型,比较不同分型患者的临床特征,并分析子宫内膜癌淋巴结转移的影响因素。结果:74例子宫内膜癌患者中错配修复缺陷型20例(27.0%),POLE突变型2例(2.7%),p53野生型34例(46.0%),p53突变型18例(24.3%)。4种分子分型患者在淋巴结转移(P=0.004)、临床分期(P=0.018)和病理分级(P=0.036)方面差异有统计学意义。二分类Logistic回归分析显示p53突变型(OR=27.669,95%CI:3.224~237.480,P=0.002)和肌层浸润≥1/2(OR=22.046,95%CI:4.185~116.146,P<0.001)是淋巴结转移的危险因素。结论:分子分型可为术前决策提供重要参考,对于术前诊断性刮宫标本的ProMisE分子分型为p53突变型的患者,淋巴结转移风险高,术中可能需要扩大手术范围。 展开更多
关键词 子宫内膜肿瘤 promisE分子分型 DNA错配修复 突变 基因 淋巴转移
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部